New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill A780

Introduced
1/9/24  

Caption

Requires entities to accept confirmation of prior COVID-19 infection or protective immune response against COVID-19 when proof of vaccination is required.

Impact

The proposed legislation highlights a significant shift in how vaccination policies are framed, specifically regarding admitting individuals into public and occupational spaces. The intent is to acknowledge those with natural immunity, reducing their compulsion to be vaccinated against their personal choice or health considerations. By framing natural immunity as equivalent to vaccine proof, A780 seeks to protect the rights of individuals who cannot or choose not to receive the vaccine, particularly in settings such as educational institutions and workplaces.

Summary

Assembly Bill A780, sponsored by Assemblyman Gregory P. McGuckin, proposes significant changes regarding vaccination requirements in New Jersey. The bill mandates that any entity requiring proof of vaccination against SARS-CoV-2 must also accept confirmation of a prior COVID-19 infection or a protective immune response as adequate proof. This measure aims to provide an alternative for individuals who have natural immunity due to prior infection, thus preventing discrimination based on vaccination status. The bill focuses on ensuring that individuals who recovered from COVID-19 have equal access to employment and services as those who are vaccinated.

Contention

Despite its protective intentions, Assembly Bill A780 may generate contention among stakeholders. Proponents argue that recognizing natural immunity helps foster a fairer environment for those impacted by the pandemic's policies. Critics, however, may raise concerns about the potential health implications and the necessity of vaccinations in safeguarding public health. Debate may center on whether relying on self-affirmed natural immunity could lead to a resurgence in COVID-19 cases, particularly in environments where high vaccination rates are crucial for herd immunity.

Companion Bills

NJ S380

Same As Requires entities to accept confirmation of prior COVID-19 infection or protective immune response against COVID-19 when proof of vaccination is required.

NJ S237

Carry Over Requires entities to accept confirmation of prior COVID-19 infection or protective immune response against COVID-19 when proof of vaccination is required.

NJ A2170

Carry Over Requires entities to accept confirmation of prior COVID-19 infection or protective immune response against COVID-19 when proof of vaccination is required.

Previously Filed As

NJ A4781

Requires entities to accept confirmation of prior COVID-19 infection or protective immune response against COVID-19 when proof of vaccination is required.

NJ A3452

Establishes criminal penalties for production, sale, and use of false COVID-19 vaccination verification card; requires AG to establish COVID-19 vaccination fraud prevention program.

NJ S1149

Prohibits mandatory vaccination against COVID-19 as condition of attending public K-12 schools.

NJ A2688

Prohibits mandatory vaccination against COVID-19 as condition of attending public K-12 schools.

NJ A845

Restricts establishment of mandates to become vaccinated against coronavirus disease 2019 (COVID-19); establishes reimbursement program to cover certain out-of-pocket costs incurred in obtaining COVID-19 vaccine.

NJ A858

Prohibits public institutions of higher education from requiring vaccinations against COVID-19 and monkeypox for students who attend remotely.

NJ S110

Establishes immunity for businesses against damage claims for COVID-19 exposure; excludes reckless or intentional conduct.

NJ A368

Prohibits institutions of higher education from requiring students to receive COVID-19 vaccination.

NJ HB4510

Prohibit the requirement of a COVID-19 vaccination as a prerequisite for any state funded program or activity

NJ A872

Prohibits discrimination against individuals who have not received COVID-19 vaccine.

Similar Bills

No similar bills found.